Weight loss at a cost: Semaglutide and PYY3-36 aggravate pre-existing metabolic osteoporosis in female Wistar rats
Bone · 2027-03 · 216 · 118170
DOI: 10.1016/j.bone.2026.118170 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bone, 2027-03. Verfasst von Simon Kloock und 11 weiteren Autor:innen. Beteiligte Einrichtung: University of Wuerzburg, University Hospital Wuerzburg, Department of Internal Medicine, Division of Endocrinology and Diabetes, Wuerzburg, Germany. …. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bristol-Myers Squibb Company, German Research Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Wuerzburg, University Hospital Wuerzburg, Department of Internal Medicine, Division of Endocrinology and Diabetes, Wuerzburg, Germany. Electronic address: kloock_s@ukw.de.
- University of Wuerzburg, University Hospital Wuerzburg, Department of Internal Medicine, Division of Endocrinology and Diabetes, Wuerzburg, Germany.
- University of Wuerzburg, University Hospital Wuerzburg, Comprehensive Heart Failure Center, Wuerzburg, Germany.
- University of Wuerzburg, University Hospital Wuerzburg, Department of Psychiatry, Psychosomatics and Psychotherapy, Center of Mental Health, Wuerzburg, Germany.
- University of Wuerzburg, University Hospital Wuerzburg, Department of Internal Medicine, Division of Endocrinology and Diabetes, Wuerzburg, Germany; University of Wuerzburg, University Hospital Wuerzburg, Core Unit Clin…
- Institute of Orthopaedic Research and Biomechanics, University of Ulm, Ulm, Germany.
Förderung
- Bristol-Myers Squibb Company
- German Research Foundation
Zitieren
APA
Kloock, S., Zytner, P., Geiger, N., Sequeira, V., Schmitt-Böhrer, A. G., Felker, J., Sarwar, H., Weich, A., Ignatius, A., Fassnacht, M., Haffner-Luntzer, M., & Dischinger, U. (2027). Weight loss at a cost: Semaglutide and PYY3-36 aggravate pre-existing metabolic osteoporosis in female Wistar rats. Bone, 216, 118170. https://doi.org/10.1016/j.bone.2026.118170
Vancouver
Kloock S, Zytner P, Geiger N, Sequeira V, Schmitt-Böhrer AG, Felker J, et al. Weight loss at a cost: Semaglutide and PYY3-36 aggravate pre-existing metabolic osteoporosis in female Wistar rats. Bone. 2027;216:118170. doi:10.1016/j.bone.2026.118170
BibTeX
@article{Kloock2027,
author = {Kloock, Simon and Zytner, Palina and Geiger, Niklas and Sequeira, Vasco and Schmitt-Böhrer, Angelika G and Felker, Jasmin and Sarwar, Humma and Weich, Alexander and Ignatius, Anita and Fassnacht, Martin and Haffner-Luntzer, Melanie and Dischinger, Ulrich},
title = {Weight loss at a cost: Semaglutide and PYY3-36 aggravate pre-existing metabolic osteoporosis in female Wistar rats},
journal = {Bone},
year = {2027},
volume = {216},
pages = {118170},
doi = {10.1016/j.bone.2026.118170}
}
EUVIMED